Literature DB >> 3706353

Adverse reactions to nonsteroidal anti-inflammatory drugs. Diclofenac compared with other nonsteroidal anti-inflammatory drugs.

W M O'brien.   

Abstract

The most common adverse effects of nonsteroidal anti-inflammatory drugs are gastritis, peptic ulceration, and depression of renal function, all of which result primarily from prostaglandin inhibition. The types of side effects observed with diclofenac are similar to those of other nonsteroidal anti-inflammatory drugs and are unavoidable given that the drugs are prostaglandin inhibitors. However, the incidences of such side effects may be lower with diclofenac than with some of the other nonsteroidal anti-inflammatory drugs. Worldwide experience with diclofenac exceeds 7.6 million patient-years, which should provide estimates of the frequency of very rare adverse reactions. The latter include blood dyscrasias, erythema multiforme, hepatitis, and others, such as aseptic meningitis, anaphylaxis, and urticaria. Moreover, some nonsteroidal anti-inflammatory drugs appear to have unique side-effect profiles. Examples include a higher incidence of ulceration and erythema multiforme with piroxicam, and acute pancreatitis, in rare instances, with sulindac. From a careful survey of the world's accumulated literature and reports to CIBA-GEIGY, diclofenac does not appear to have any unusual adverse reactions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3706353     DOI: 10.1016/0002-9343(86)90084-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  13 in total

1.  Severe anaphylactic reaction to diclofenac.

Authors:  Atul A Jha; Vijay Bohra; Vineet Behera
Journal:  Med J Armed Forces India       Date:  2014-11-07

Review 2.  Drug-induced aseptic meningitis: diagnosis and management.

Authors:  S Jolles; W A Sewell; C Leighton
Journal:  Drug Saf       Date:  2000-03       Impact factor: 5.606

3.  Pharmacokinetics of diclofenac and inhibition of cyclooxygenases 1 and 2: no relationship to the CYP2C9 genetic polymorphism in humans.

Authors:  Julia Kirchheiner; Ingolf Meineke; Nadine Steinbach; Christian Meisel; Ivar Roots; Jürgen Brockmöller
Journal:  Br J Clin Pharmacol       Date:  2003-01       Impact factor: 4.335

4.  Tablet formulation study of spray-dried sodium diclofenac enteric-coated microcapsules.

Authors:  S Y Lin; Y H Kao
Journal:  Pharm Res       Date:  1991-07       Impact factor: 4.200

Review 5.  Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

6.  Misoprostol coadministered with diclofenac for prevention of gastroduodenal ulcers. A one-year study.

Authors:  N M Agrawal; H E Van Kerckhove; L J Erhardt; G S Geis
Journal:  Dig Dis Sci       Date:  1995-05       Impact factor: 3.199

Review 7.  A risk-benefit appraisal of injectable NSAIDs in the management of postoperative pain.

Authors:  L S Nuutinen; J O Laitinen; T E Salomäki
Journal:  Drug Saf       Date:  1993-11       Impact factor: 5.606

8.  Comparison of aceclofenac with piroxicam in the treatment of osteoarthritis.

Authors:  M Peréz Busquier; E Calero; M Rodríguez; P Castellon Arce; A Bermudez; L F Linares; J Mesa; C Ffernandez Crisostomos; C Garcia; A Garcia Lopez; A Valenzuela; A Povedano; S Garcia Perez; M A Lopez; R Caliz; F Garcia Villalba; M Cano; F Gines Martinez; J Gonzalez; M A Caracuel; R Roldan; M Guzman Ubeda; A Gonzalez; I L Marenco de la Fuente; M Alepuz Pou
Journal:  Clin Rheumatol       Date:  1997-03       Impact factor: 2.980

9.  Piroxicam induced submassive necrosis of the liver.

Authors:  D Paterson; P Kerlin; N Walker; S Lynch; R Strong
Journal:  Gut       Date:  1992-10       Impact factor: 23.059

10.  Anaphylactic reaction to intravenous diclofenac.

Authors:  Ranju Singh; Deepak Bansal; Neha Baduni; Homay Vajifdar
Journal:  Indian J Crit Care Med       Date:  2011-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.